The major findings of this study are as follows: (i) Development of a novel Tl
+ flux based assay for the mK
ATP channel; (ii) Time-dependent loss of mK
ATP channel activity is a genuine run-down phenomenon and is reversed by PIP
2; (iii) FLX blocks both mK
ATP channel activity and IPC-mediated cardioprotection. This is the first demonstration of the modulation of a mitochondrial ion channel by PIP
2, and the first identification of a mitochondrial ion channel target for FLX. Collectively, the data support the concept that mK
ATP contains a bona fide K
IR channel. The effects of FLX on IPC may elucidate some of the reported negative impact of SSRI use on the outcome of cardiac surgery in humans.
41Work on the mK
ATP channel to date has relied on a variety of assays, many of which measure downstream effects of mitochondrial K
+ uptake such as changes in respiration,
42 matrix alkalinization,
42 flavoprotein fluorescence,
43 and swelling induced light scatter.
42 Such methods are limited by the ability of other mitochondrial phenomena (e.g. electron transport chain activity, volume changes, membrane potential) to interfere with the measured parameters. Direct measurement of mitochondrial K
+ fluxes using the potassium-binding fluorescent indicator (PBFI) is difficult because its
Kd for K
+ of ~8 mmol/L
42 would result in saturation at typical intramitochondrial K
+ levels (~150 mmol/L).
44 Thus herein we chose to exploit another property of K
+ channels, their ability to transport Tl
+ as a surrogate for K
+.
21, 27 While Tl
+ acetate has previously been used in swelling-based studies on mK
ATP45, this study is the first application of a Tl
+ sensitive probe, BTC-AM,
28–30 to study mK
ATP.
The kinetics of the Tl
+ based mK
ATP channel assay are superior to those of the swelling based assay.
16 Following Tl
+ addition maximal fluorescence is attained within 2–4 s., compared to a time-lag of 20–30 s. for maximal signal intensity in the osmotic swelling assay. Unfortunately the high flux rate of Tl
+ through K
+ channels (~2x K
+ flux
21), coupled with the relatively slow mixing time in the fluorescence cuvet, does not permit precise channel kinetics to be determined in this apparatus. Current best estimates for mK
ATP channel conductivity range from 10 to 300 pS.
15, 46, 47Another barrier to investigating the mK
ATP channel has been the rapid loss of channel activity over time in isolated mitochondrial preparations.
20 Previous work showed that the purified mK
ATP channel runs-down in an electrophysiology setting and can be re-activated by very high concentrations of UDP.
48 However, the cause of channel activity loss in intact mitochondria was unknown, and could easily be due to proteolytic degradation. The finding herein that time-dependent mK
ATP channel inactivation in intact mitochondria can be reversed by PIP
2 indicates this is a genuine run-down phenomenon, which is a common property of K
IR channels.
49K
ATP channels were the first channels identified to depend on phosphoinositides such as PIP
2,
22, 23 and this is the first study to identify a mitochondrial ion channel that responds to PIP
2. Such regulation of mK
ATP channel activity by PIP
2 may have implications for the function of this channel in IPC. PIP
2 has been found in mitochondrial membranes,
50 but its endogenous source in mitochondria is unknown. Notably, the run-down of a planar lipid bilayer reconstituted mK
ATP was reversed by ATP/Mg
2+,
51 suggesting the mitochondrial high energy phosphate pool may be important in maintaining membrane lipid phosphorylation status. However, this phenomenon required very specific experimental conditions (i.e. addition and removal of ATP/Mg
2+ to and from different sides of the membrane in a particular order), and attempts to reproduce this in isolated mitochondria were unsuccessful (data not shown). The role of lipid kinases (e.g., PI
3K), phospholipases (e.g., PLC), and other components of the IP
3/DAG signaling pathway in regulating mK
ATP is also unknown, but the involvement of such signaling components in IPC
52, 53 suggests a potential novel pharmacological target (i.e., mitochondrial PIP
2 turnover) to modulate preconditioning.
The Tl
+ assay was also used to probe the response of mK
ATP to nucleotides (
Figure S2). The mK
ATP EC
50 for UDP (~20 μmol/L) was closer to that of K
IR6.2 (~200 μmol/L) than K
IR6.1 (~4 mmol/L), and the mK
ATP IC
50 for ATP (~4.5 μmol/L) was also closer to that of K
IR6.2 (~15 μmol/L) than K
IR 6.1 (~350 μmol/L). While these data agree with previous studies on mK
ATP,
48 a variety of labeling, electrophysiological and genetic studies across multiple species and tissues have suggested the presence of either K
IR6.1, K
IR6.2, both, or neither in mitochondria.
6, 10, 54–62 An overall consensus is that mK
ATP likely contains a K
IR channel, but the definitive assignment of a particular K
IR isoform is not yet possible.
The discovery that mK
ATP activity is blocked by FLX is also consistent with the consensus that mK
ATP contains a K
IR. Fluoxetine has previously been shown to inhibit K
IR channels, while related SSRIs (e.g. zimelidine) had no effect.
24, 25 Our data (
Figure S3) suggest that K
IR6 channels may be the most sensitive to FLX of all K
IR isoforms,
24, 25, 40, 63 and in agreement with this the mK
ATP exhibits a strikingly low FLX IC
50 of 2.4 μmol/L (). Physiological concentrations of FLX are in the range of 1 – 20 μmol/L.
63 The fact that FLX is a lipophilic cation (LogP 4.8),
64 coupled with the highly membranous nature of mitochondria, may serve to concentrate FLX in the organelle. In a mitochondria-rich tissue such as myocardium, the mitochondrion may be a primary target for FLX.
The discovery that FLX can block IPC-mediated cardioprotection is both consistent with its effect on mK
ATP activity, and consistent with a critical role for mK
ATP in IPC signaling.
1, 16, 65 The lack of effect of another SSRI, zimelidine, on either IPC or mK
ATP activity suggests that this effect is not mediated via the SSRI mode of action. The observation that FLX also blocks mK
ATP channel opening by the highly specific agonist AA5 also suggests a direct mK
ATP effect. Furthermore, the lack of effect of FLX on FCCP-mediated cardioprotection, which is completely independent of mK
ATP channels,
31, 32 suggests that the protection-blocking effect of FLX is specific to mK
ATP channel-mediated protection, and does not extend to all modes of protection. The current lack of a molecular identity for the mK
ATP does not permit decisive knock-out experiments to verify whether the effects of FLX observed in the intact heart are mediated by mK
ATP.
In the US, antidepressants are the most commonly prescribed class of medication,
66 with FLX alone prescribed >23 million times in 2008.
67 Although SSRIs are known to negatively impact the outcome of cardiac surgery,
41 they are widely prescribed to patients with acute coronary syndrome.
68 Notably, while IPC elicits solid protection in animal models of IR injury, its application in humans is limited by confounding effects such as age,
69 gender,
70 diabetes,
13 and other medications.
71 To this list of medications FLX must now be added, with the implication that successful cardioprotection in humans may require FLX withdrawal. Furthermore, the mood enhancer lithium is also known to both increase cardiac PIP
2 lelvels
72 and to induce cardioprotection,
73 suggesting that some of the protective effects of lithium previously attributed to GSK-3β inhibition
73 may be mediated via the mK
ATP channel.
In summary, we have developed herein a novel assay for the mKATP channel, and used this assay to reveal novel sensitivities of the channel to phosphoinositides and antidepressants. It is anticipated that this assay may find widespread use in the mKATP field, leading ultimately to the identification of this important channel.
Novelty and Significance (Wojtovich et al.)What is known?
- The mitochondrial ATP-sensitive potassium channel (mKATP) mediates protection from cardiac ischemia reperfusion injury by ischemic preconditioning.
- The molecular identity of the mKATP remains controversial and the validity of current methods to assay mKATP activity is disputed.
- Another limitation to the investigation of this channel is the rapid (~ 1 hr.) loss of channel activity following mitochondrial isolation.
What new information does this article contribute?
- We describe a novel thallium flux assay for measurement of mKATP activity.
- The rapid loss of mKATP activity after isolation is shown to be due to classical channel run-down, and is recovered by the phospholipid PIP2.
- Both the mKATP channel and ischemic preconditioning are inhibited by fluoxetine (Prozac™).
Summary of Novelty and Significance
Cardiac ischemia/reperfusion (IR) injury is an important worldwide morbidity factor. Strategies to protect the heart from IR injury (such as during heart attack) are limited, but one promising avenue is ischemic preconditioning (IPC). The mitochondrial ATPsensitive K+ channel (mKATP) has been suggested to mediate the protection afforded by IPC; however, the molecular identity of this channel is unknown, and its assay is also technically challenging, thus hindering drug-development efforts. Using a Tl+-sensitive fluorophore, a novel assay was developed herein to measure mKATP activity. Using this assay, we show that loss of mKATP channel activity over time is reversed by the lipid PIP2. These findings should greatly facilitate mKATP research, hopefully leading to a molecular identity. Furthermore, this is the first report of a PIP2 sensitive phenomenon in mitochondria; it may possibly relate to the mechanism of channel regulation in IPC itself. Finally, we found that the antidepressant fluoxetine (Prozac™) inhibited mKATP and also blocked the protective effects of IPC. Given the widespread use of fluoxetine in cardiac patients, this may have important implications for the potential application ofIPC in humans.